Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.36% | 5.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.36% | 5.76% | |||
| Cost of Revenue | -6.56% | 5.11% | |||
| Gross Profit | -5.92% | 7.27% | |||
| SG&A Expenses | -5.35% | 7.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -2,313.64% | -112.19% | |||
| Total Operating Expenses | -6.39% | 5.79% | |||
| Operating Income | -5.82% | 5.25% | |||
| Income Before Tax | -14.88% | 6.57% | |||
| Income Tax Expenses | -43.68% | 10.28% | |||
| Earnings from Continuing Operations | 14.59% | 3.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.59% | 3.02% | |||
| EBIT | -5.82% | 5.25% | |||
| EBITDA | 11.34% | 4.48% | |||
| EPS Basic | 15.66% | 2.47% | |||
| Normalized Basic EPS | -15.89% | 4.90% | |||
| EPS Diluted | 15.66% | 2.47% | |||
| Normalized Diluted EPS | -15.89% | 4.90% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
